After Hours Summary: TNDM +19%, PANW +9%, JAZZ +8%, MELI +7% are higher, while WTW -31%, ELF -17%, WLL -11%, MYL -10%, TIVO -8%, BGS -7% are lower following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: TNDM +18.6%, OPRX +12.4%, FTR +9.6%, PANW +9.1%, GWPH +8%, JAZZ +8%, MELI +7.4%, IMAX +6.5%, SUPN +5.7%, SE +5.6%, MED +4.8%, HEI +4.2% (light volume), IMMR +3.9%, PLNT +3.5%, AXGN +3.4%, CPE +3%, TOL +3%, PZZA +2.9%, CGBD +2%, OAS +1.7%, VEEV +1.5%, RRGB +1.2%
Companies trading higher in after hours in reaction to news: MAXR +8.6% (ahead of earnings Feb 28), DF +7.7% (commences review to explore and evaluate potential strategic alternatives), LTHM +5.5% (to join S&P SmallCap 600), HRTX +3.5% (announces FDA approval for CINVANTI for IV use NDA), REI +3.4% (light volume; Ring Energy to acquire North Central Basin Assets from Wishbone Energy Partners), IOVA +2.4% (ahead of earnings tomorrow), NIO +2% (continued strength), GE +1.6% (to focus on power, renewable energy, aviation and healthcare segments; from 10-K: Targeting leverage <2.5x and dividend in-line with peers over time), CPB +1.5% (signs definitive agreement for the sale of Garden Fresh Gourmet to an affiliate of Fountain of Health USA), TLRY +1.1% (signs multi-year agreement for cannabis and hemp extraction with Valens GroWorks), BHC +1% (light volume; Bausch Health to acquire certain assets of Synergy Pharmaceuticals [SGYP] for cash purchase price of approx. $195 mln)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: WTW -30.7%, ELF -17.2% (also to exit the stand-alone e.l.f. retail store business, CFO resigns), EVH -15.5%, VICR -13.7%, INGN -11.5%, WLL -11.3%, CLGX -11.1%, MYL -10.1%, TIVO -7.9%, BGS -6.9%, BNFT -6.7% (also announces secondary offering of an aggregate of 5,704,758 shares of common stock), CERS -6.3% (ticking lower), DVAX -5.3% (light volume), AAXN -4.5%, EOG -3.2%, ENPH -2.8%, HPR -2.7%, ACAD -2.4%
Companies trading lower in after hours in reaction to news: KPTI -19.7% (FDA AdCom votes to delay potential approval of selinexor until results of the randomized phase 3 BOSTON trial are available), LPSN -3.4% (to offer private offering of $150.0 mln of Convertible Senior Notes due 2024), VNOM -2.7% (announces public offering of 8.0 mln common units), NYMT -2.6% (prices public offering of 15 mln shares of common stock for gross proceeds of approx $90.0 mln), EQIX -1.4% (announces proposed public offering of $900 mln of common stock), HCP -0.5% (entered into $1 bln 'at-the-market' equity offering sales agreement), QTS -0.5% (prices 6.75 mln share Class A common stock offering at $41.50/share - includes 4 mln sold by the company)